Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
49.00
-0.13 (-0.26%)
Feb 18, 2026, 10:01 AM EST

Novo Nordisk Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
218,822227,208384,855461,550304,426256,201
Market Cap Growth
-41.74%-40.96%-16.62%51.61%18.82%58.01%
Enterprise Value
235,265237,997382,368458,427302,773252,890
Last Close Price
49.3151.0584.49100.4366.8854.39
PE Ratio
13.5914.1127.4537.1938.1635.07
PS Ratio
4.504.689.5513.4011.9711.90
PB Ratio
7.177.4519.3229.2125.3823.68
P/TBV Ratio
21.7522.5884.8767.4365.1060.74
P/FCF Ratio
23.6124.5137.5637.4531.7534.42
P/OCF Ratio
11.6912.1322.9228.5826.8630.45
EV/Sales Ratio
4.814.909.4913.3111.9111.74
EV/EBITDA Ratio
9.609.8818.9127.9225.9825.93
EV/EBIT Ratio
10.5810.7719.8329.5327.8727.92
EV/FCF Ratio
25.3825.6837.3237.2031.5733.97
Debt / Equity Ratio
0.680.680.720.250.310.38
Debt / EBITDA Ratio
0.850.850.700.240.310.41
Debt / FCF Ratio
2.222.221.390.330.390.55
Net Debt / Equity Ratio
0.540.540.53-0.030.030.13
Net Debt / EBITDA Ratio
0.680.680.53-0.030.030.14
Net Debt / FCF Ratio
1.761.761.04-0.040.030.19
Asset Turnover
0.610.610.750.840.810.83
Inventory Turnover
1.201.201.201.261.291.24
Quick Ratio
0.540.540.530.620.670.65
Current Ratio
0.800.800.740.820.900.86
Return on Equity (ROE)
60.70%60.70%80.77%88.07%72.00%71.24%
Return on Assets (ROA)
17.43%17.43%22.26%23.55%21.69%21.81%
Return on Invested Capital (ROIC)
41.13%42.60%68.23%88.56%73.42%67.98%
Return on Capital Employed (ROCE)
43.00%43.00%56.00%72.30%62.80%62.30%
Earnings Yield
7.36%7.09%3.64%2.69%2.62%2.85%
FCF Yield
4.24%4.08%2.66%2.67%3.15%2.90%
Dividend Yield
3.34%3.60%1.87%1.39%1.33%1.46%
Payout Ratio
50.53%50.53%43.71%37.96%45.57%45.05%
Buyback Yield / Dilution
0.34%0.34%0.71%1.10%1.34%1.58%
Total Shareholder Return
3.68%3.95%2.58%2.48%2.67%3.04%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.